Biotricity, Inc. BTCY
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -42.78% | 83.25% | 41.66% | 55.76% | 81.81% |
| Total Depreciation and Amortization | 13.70% | 13.69% | 13.57% | 13.56% | 7,393.33% |
| Total Amortization of Deferred Charges | 27.99% | 24.74% | -36.28% | -40.54% | -86.58% |
| Total Other Non-Cash Items | 1,882.38% | -99.63% | 163.06% | -34.78% | -97.48% |
| Change in Net Operating Assets | 6,822.00% | 94.30% | -176.98% | 11.09% | -93.46% |
| Cash from Operations | 235.83% | 94.79% | -740.30% | 204.66% | 75.01% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -132.69% | 12.77% | -52.23% | -- |
| Total Debt Repaid | -- | 123.62% | 72.73% | -5.73% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.69% | 1.64% | -1.69% | -1.67% | 50.83% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -143.81% | -155.45% | 69.72% | -207.77% | -49.82% |
| Foreign Exchange rate Adjustments | 101.10% | -97.59% | 78.56% | 720.00% | 38.95% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,113.41% | 26.23% | -115.49% | -214.21% | 103.81% |